Advanced Drainage Systems heads into its June 18 earnings report with a consensus buy rating and a stock that hasn't earned it back yet.
The analyst tone into the print is constructive but cautious. Jefferies initiated coverage with a Buy and a $175 target just days ago, and RBC Capital lifted its target modestly to $170 while keeping an Outperform. Those fresh positives land against a backdrop of widespread target cuts: UBS, Keybanc, Oppenheimer, and Barclays all trimmed their numbers in late May, following the prior earnings release. The direction is clear — the Street still likes the story, but it's marking down expectations. The mean target is $179.70, roughly 33% above the current price of $134.95, which reflects how far the stock has fallen from where analysts were anchoring valuations earlier in the year.
The bull case rests on WMS's structural positioning in stormwater and wastewater infrastructure — a market driven by regulatory mandates rather than pure construction cycles — combined with pricing power and expanding margins. Bears counter that residential and commercial construction activity is softening, and the NDS acquisition carries integration risk at a price that may prove generous. The PE multiple has re-rated to around 20x, up roughly 1 point over the past month, suggesting the market is beginning to price in a recovery even as near-term earnings estimates remain under pressure. The EPS momentum factor ranks in the bottom quintile on a 30-day basis, a signal that forecast revisions have been running negative heading into the release.
The short setup offers little drama. Short interest is moderate at 3.7% of the free float and has drifted 4% lower over the past month. Borrowing costs are negligible at 0.41%, and availability is exceptionally loose at over 2,700% — meaning the lending pool is far from tapped and there is no meaningful squeeze risk. Options positioning is similarly unexcited: the put/call ratio at 0.87 sits fractionally below its 20-day average, with a z-score close to zero, and well off the elevated readings above 1.1 that persisted through early May. That defensive overhang from a month ago has clearly unwound. The stock recovered 3.7% on the week entering the print but remains down 3.5% over the past month, and the most recent earnings history shows a modest initial dip of around 2.8% followed by a partial five-day recovery — a pattern where the first read disappointed before stabilizing.
The June 18 print is therefore a test of whether the post-NDS integration narrative can be substantiated with margin and volume numbers that justify the analyst community's still-premium targets — or whether the gap between $135 and $180 widens further.
See the live data behind this article on ORTEX.
Open WMS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
